Ose Immunotherapeutics Is A Clinical Stage Biotechnology Company Based In Nantesfrancefounded In 2016The Company Specializes In Immuno Oncology And Immuno Inflammation Therapiesfocusing On First In Class Immunotherapies That Modulate The Immune System To Target Cancer And Chronic Inflammatory Diseases Ose Operates With Proprietary Drug Discovery Platforms And A Robust Clinical Pipeline Developed Through Collaborations With Academic Institutions And Industry Partnersincluding Abbvie And Boehringer Ingelheimtheir Research And Development Efforts Emphasize T Cell Activationimmune Checkpoint Regulationand Myeloid Cell Mediated Inflammation Controlkey Products In Their Pipeline Include Tedopia A Neoepitope Based Cancer Vaccine In Phase 3 Trialsand Ose 279An Anti Pd 1 Monoclonal Antibody For Solid Tumors And Lymphomasthe Company Is Committed To Addressing Unmet Medical Needs In Oncology And Inflammation Through Innovative Therapies
No conferences found for this company.
| Company Name | Ose Immunotherapeutics |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
